[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"trial:NCT07632742":3,"trial-entities:NCT07632742":98,"trial-summary:NCT07632742":101},{"id":4,"nct_id":4,"org_study_id":5,"brief_title":6,"official_title":7,"overall_status":8,"completion_date":9,"status_verified_date":10,"last_update_date":11,"start_date":12,"sponsor_name":13,"lead_sponsor_class":14,"has_dmc":15,"brief_summary":16,"detailed_description":17,"conditions":18,"keywords":21,"study_type":24,"primary_purpose":25,"phases":26,"enrollment_info":28,"interventions":31,"primary_outcomes":43,"secondary_outcomes":48,"sex":58,"minimum_age":59,"maximum_age":60,"healthy_volunteers":61,"eligibility_criteria":62,"std_ages":72,"locations":75,"central_contacts":90,"overall_officials":92,"references":96,"see_also_links":97},"NCT07632742","STU00225001","Moses 2.0 vs Magneto for HoLEP - a Randomized Controlled Trial","MOSES 2.0 vs Quanta Magneto 150 Holmium Laser for Holmium Laser Enucleation of the prostate-a Randomized Controlled Trial","RECRUITING","2028-06","2026-04","2026-06-08","2026-06","Northwestern University","OTHER",false,"The objective of this study is to compare the Magneto 150 holmium laser to the current MOSES 2.0 technology to see if there is a benefit in decreased hemostasis time intraoperatively.","The Magneto 150 is a high-powered 150W holmium laser that offers similar pulse-modulation benefits of MOSES 2.0, which facilitates effective dissection and enucleation of the tissue plane while also offering a new first-of-its kind proprietary Magneto setting which allows for very low peak power of 500W and longer pulse duration which allows for better hemostasis.",[19,20],"Enlarged Prostate (BPH)","Benign Prostatic Hyperplasia",[22,23],"HoLEP","Holmium laser","INTERVENTIONAL","TREATMENT",[27],"NA",{"count":29,"type":30},180,"ESTIMATED",[32,38],{"type":33,"name":34,"description":35,"armGroupLabels":36},"DEVICE","Magneto 150 holmium laser","The HoLEP procedure will be performed using the Quanta Magneto 150 holmium laser",[37],"Magneto 150",{"type":33,"name":39,"description":40,"armGroupLabels":41},"Moses 2.0 holmium laser","The HoLEP procedure will be performed using the Moses 2.0 holmium laser",[42],"Moses 2.0",[44],{"measure":45,"description":46,"timeFrame":47},"Mean hemostasis time","Overall intraoperative hemostasis time","During surgery",[49,52,55],{"measure":50,"description":51,"timeFrame":47},"Mean (average) enucleation time","Time taken to surgically remove excess prostate tissue while leaving the shell of the prostate intact and within the body.",{"measure":53,"description":54,"timeFrame":47},"Total operative time","Time taken from official procedure start to completion (not accounting for the time that the patient is wheeled in, prepped and out of the operating room).",{"measure":56,"description":57,"timeFrame":47},"Hemostasis efficiency","minutes\u002Fgram (prostate tissue removed)","MALE","18 Years","100 Years",true,{"inclusion":63,"exclusion":66,"raw_text":71},[64,65],"Undergoing HoLEP for the treatment of bothersome lower urinary tract symptoms","Internet access and a device to complete postoperative questionnaires (smartphone, tablet, laptop or desktop computer)",[67,68,69,70],"Patients who lack decisional capacity","Patients unable to read\u002Fspeak English","Patients who are on a blood thinner (anticoagulation medication)","Patients who do not have internet access to complete postoperative surveys","Inclusion Criteria:\n\n* Undergoing HoLEP for the treatment of bothersome lower urinary tract symptoms\n* Internet access and a device to complete postoperative questionnaires (smartphone, tablet, laptop or desktop computer)\n\nExclusion Criteria:\n\n* Patients who lack decisional capacity\n* Patients unable to read\u002Fspeak English\n* Patients who are on a blood thinner (anticoagulation medication)\n* Patients who do not have internet access to complete postoperative surveys",[73,74],"ADULT","OLDER_ADULT",[76],{"facility":13,"status":8,"city":77,"state":78,"zip":79,"country":80,"contacts":81,"geoPoint":87},"Chicago","Illinois","60611","United States",[82],{"name":83,"role":84,"phone":85,"email":86},"Alyssa McDonald, MPH","CONTACT","312-695-8146","alyssa.mcdonald@northwestern.edu",{"lat":88,"lon":89},41.85003,-87.65005,[91],{"name":83,"role":84,"phone":85,"email":86},[93],{"name":94,"affiliation":13,"role":95},"Perry Xu, MD","PRINCIPAL_INVESTIGATOR",[],[],{"nct_id":4,"conditions":99,"biomarkers":100},[20],[],{"nct_id":4,"found":15,"summary":102,"prompt_version":102},null]